Home - Products - Membrane Transporter/Ion Channel - Sodium Channel - Ralitoline

Ralitoline

CAS No. 1089085-40-4

Ralitoline( —— )

Catalog No. M34390 CAS No. 1089085-40-4

Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	182	In Stock
10MG	274	In Stock
25MG	448	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ralitoline
Note

Research use only, not for human use.
Brief Description

Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
Description

Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Membrane Transporter/Ion Channel
Target

Sodium Channel
Recptor

Sodium Channel
Research Area

——
Indication

——

Chemical Information

CAS Number

1089085-40-4
Formula Weight

296.77
Molecular Formula

C13H13ClN2O2S
Purity

>98% (HPLC)
Solubility

——
SMILES

C(C(NC1=C(C)C=CC=C1Cl)=O)=C2N(C)C(=O)CS2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

AZ194

CRMP2-Ubc9-NaV1.7 inhibitor 194, is a CRMP2-Ubc9-NaV1.7 inhibitor.
Aneratrigine hydroch...

Aneratrigine hydrochloride is a sodium channel protein type 9 subunit blocker that may be used for the prevention or treatment of sodium channel blocker-related diseases.
Crobenetine

Crobenetine (BIII 890 CL) Free Base is a selective NaV channel blocker that eliminates VTD-induced [Ca2+] elevation.

Sign In Join Free